ALK7:actriib heteromultimers and uses thereof
AssigneeAcceleron Pharma Inc.
InventorsRavindra Kumar, Asya Grinberg, Dianne Sako, Robert Scott Pearsall, Roselyne Castonguay, Gang Li, Yossi Dagon, John Knopf
Life of this patent
Estimating the term…
Loading patent…
AssigneeAcceleron Pharma Inc.
InventorsRavindra Kumar, Asya Grinberg, Dianne Sako, Robert Scott Pearsall, Roselyne Castonguay, Gang Li, Yossi Dagon, John Knopf
Estimating the term…
In certain aspects, the disclosure provides soluble heteromeric polypeptide complexes comprising an extracellular domain of an ALK7 receptor and an extracellular domain of ActRIIB In certain aspects, these ALK7:ActRIIB heteromultimers are can be used to improve metabolic parameters in a patient in need thereof. In certain aspects, these ALK7:ActRIIB heteromultimers are can be used to treat or prevent one or more kidney-associated disease or condition in a patient in need thereof.
A method of treating a kidney disorder in a subject in need thereof, comprising administering to the subject a soluble recombinant heteromultimer comprising:
Dependencies are inferred from the claim text.